Phase II evaluation of nedaplatin and paclitaxel in patients with metastatic esophageal carcinoma

Cancer Chemotherapy and Pharmacology

Volumn 64, Issue 2, 2009, Pages 327-333

  Gong, Youling ^a   Ren, Li ^a   Zhou, Lin ^a   Zhu, Jiang ^a   Huang, Meijuan ^a   Zhou, Xiaojuan ^a   Wang, Jin ^a   Lu, You ^a   Hou, Mei ^a   Wei, Yuquan ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

Esophageal carcinoma; Metastasis; Nedaplatin; Paclitaxel

Indexed keywords

NEDAPLATIN; PACLITAXEL;

ADULT; AGED; ALOPECIA; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DRUG DOSE REDUCTION; DRUG DOSE REGIMEN; DRUG HYPERSENSITIVITY; ESOPHAGUS CANCER; ESOPHAGUS CARCINOMA; FEMALE; HUMAN; INFORMED CONSENT; KAPLAN MEIER METHOD; MALE; METASTASIS; MULTIPLE CYCLE TREATMENT; MYALGIA; NAUSEA AND VOMITING; NEUROPATHY; NEUTROPENIA; PATIENT CODING; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; REPEATED DRUG DOSE; SURVIVAL RATE; TREATMENT RESPONSE;

ADENOCARCINOMA; ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BONE NEOPLASMS; CARCINOMA, SQUAMOUS CELL; ESOPHAGEAL NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HUMANS; LUNG NEOPLASMS; LYMPHATIC METASTASIS; MALE; MAXIMUM TOLERATED DOSE; MIDDLE AGED; NEOPLASM STAGING; ORGANOPLATINUM COMPOUNDS; PACLITAXEL; PROGNOSIS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 67349193200     PISSN: 03445704     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00280-008-0874-8     Document Type: Article

References (23)

1. JA Ajani DH Ilson K Daugherty R Pazdur PM Lynch DP Kelsen 1994 Activity of taxol in patients with squamous cell carcinoma and adenocarcinoma of the esophagus J Natl Cancer Inst 86 1086 1091 (Pubitemid 24228477)
2. DS Alberts PT Fanta KL Running LP Adair Jr DJ Garcia R Liu-Stevens SE Salmon 1997 In vitro phase II comparison of the cytotoxicity of a novel platinum analog, nedaplatin (254-S), with that of cisplatin and carboplatin against fresh, human ovarian cancers Cancer Chemother Pharmacol 39 493 497 (Pubitemid 27096764)
3. H Bleiberg T Conroy B Paillot AJ Lacave G Blijham JH Jacob L Bedenne M Namer P De Besi F Gay L Collette T Sahmoud 1997 Randomised phase II study of cisplatin and 5-fluorouracil (5-FU) versus cisplatin alone in advanced squamous cell oesophageal cancer Eur J Cancer 33 1216 1220 (Pubitemid 27359638)
4. SH Cho IJ Chung SY Song DH Yang JR Byun YK Kim JJ Lee KJ Na HJ Kim 2005 Bi-weekly chemotherapy of paclitaxel and cisplatin in patients with metastatic or recurrent esophageal cancer J Korean Med Sci 20 618 623
5. D Cunningham N Starling S Rao T Iveson M Nicolson F Coxon G Middleton F Daniel J Oates AR Norman Upper Gastrointestinal Clinical Studies Group of the National Cancer Research Institute of the United Kingdom 2008 Capecitabine and oxaliplatin for advanced esophagogastric cancer N Engl J Med 358 36 46
6. BF El-Rayes A Shields M Zalupski LK Heilbrun V Jain D Terry A Ferris PA Philip 2004 A phase II study of carboplatin and paclitaxel in esophageal cancer Ann Oncol 15 960 965 (Pubitemid 39004354)
7. T Iizuka T Kakegawa H Ide N Ando H Watanabe O Tanaka I Takagi K Isono K Ishida M Arimori 1992 Phase II evaluation of cisplatin and 5-fluorouracil in advanced squamous cell carcinoma of the esophagus: a Japanese Esophageal Oncology Group Trial Jpn J Clin Oncol 22 172 176
8. DH Ilson J Ajani K Bhalla A Forastiere Y Huang P Patel L Martin J Donegan R Pazdur C Reed DP Kelsen 1998 Phase II trial of paclitaxel, fluorouracil, and cisplatin in patients with advanced carcinoma of the esophagus J Clin Oncol 16 1826 1834
9. DH Ilson L Saltz P Enzinger Y Huang A Kornblith M Gollub E O'Reilly G Schwartz J DeGroff G Gonzalez DP Kelsen 1999 Phase II trial of weekly irinotecan plus cisplatin in advanced esophageal cancer J Clin Oncol 17 3270 3275 (Pubitemid 29470662)
10. DH Ilson RG Wadleigh LP Leichman DP Kelsen 2007 Paclitaxel given by a weekly 1-h infusion in advanced esophageal cancer Ann Oncol 18 898 902 (Pubitemid 47054088)
11. A Jemal R Siegel E Ward 2006 Cancer statistics, 2006 CA Cancer J Clin 56 106 130
12. M Kanai S Matsumoto T Nishimura 2007 Retrospective analysis of 27 consecutive patients treated with docetaxel/nedaplatin combination therapy as a second-line regimen for advanced esophageal cancer Int J Clin Oncol 12 224 227 (Pubitemid 46944642)
13. Y Kawai S Taniuchi S Okahara 2005 Relationship between cisplatin or nedaplatin-induced nephrotoxicity and renal accumulation Biol Pharm Bull 28 1385 1388 (Pubitemid 41379685)
14. T Kurata K Tamura N Yamamoto T Nogami T Satoh H Kaneda K Nakagawa M Fukuoka 2004 Combination phase I study of nedaplatin and gemcitabine for advanced non-small-cell lung cancer Br J Cancer 90 2092 2096 (Pubitemid 38869711)
15. H Kurita E Yamamoto S Nozaki S Wada I Furuta K Kurashina 2004 Multicenter phase I trial of induction chemotherapy with docetaxel and nedaplatin for oral squamous cell carcinoma Oral Oncol 40 1000 1006 (Pubitemid 39422785)
16. H Levard X Pouliquen JM Hay A Fingerhut O Langlois-Zantain M Huguier P Lozach J Testart 1998 5-Fluorouracil and cisplatin as palliative treatment of advanced oesophageal squamous cell carcinoma. A multicentre randomised controlled trial. The French associations for surgical research Eur J Surg 164 849 857 (Pubitemid 28527290)
17. J Millar P Scullin A Morrison B McClory L Wall D Cameron H Philips A Price D Dunlop M Eatock 2005 Phase II study of gemcitabine and cisplatin in locally advanced/metastatic oesophageal cancer Br J Cancer 93 1112 1116 (Pubitemid 41670694)
18. K Okuda T Hirose H Ishida S Kusumoto T Sugiyama K Ando T Shirai T Ohnishi N Horichi T Ohmori M Adachi 2008 Phase I study of the combination of nedaplatin and weekly paclitaxel in patients with advanced non-small cell lung cancer Cancer Chemother Pharmacol 61 829 835
19. MB Polee FA Eskens ME van der Burg TA Splinter PD Siersema HW Tilanus J Verweij G Stoter A van der Gaast 2002 Phase II study of bi-weekly administration of paclitaxel and cisplatin in patients with advanced oesophageal cancer Br J Cancer 86 669 673 (Pubitemid 34250803)
20. P Therasse SG Arbuck EA Eisenhauer J Wanders RS Kaplan L Rubinstein J Verweij M Van Glabbeke AT van Oosterom MC Christian SG Gwyther 2000 New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada J Natl Cancer Inst 92 205 216
21. SG Urba K Chansky PJ VanVeldhuizen RE Pluenneke JK Benedetti JS Macdonald JL Abbruzzese Southwest Oncology Group Study 2004 Gemcitabine and cisplatin for patients with metastatic or recurrent esophageal carcinoma: a southwest oncology study group Invest New Grugs 22 91 97 (Pubitemid 38196987)
22. LW Vestermark P Sørensen P Pfeiffer 2008 Chemotherapy to patients with metastatic carcinoma of the esophagus and gastro-esophageal junction. A survey of a Cochrane review Ugeskr Laeger 170 633 636
23. X Zhang L Shen J Li Y Li J Li M Jin 2008 A phase II trial of paclitaxel and cisplatin in patients with advanced squamous-cell carcinoma of the esophagus Am J Clin Oncol 31 29 33